Revance Therapeutics, Inc. (RVNC)
NASDAQ: RVNC · Real-Time Price · USD
5.29
+0.01 (0.19%)
At close: Oct 22, 2024, 4:00 PM
5.39
+0.10 (1.89%)
After-hours: Oct 22, 2024, 5:02 PM EDT
Revance Therapeutics Market Cap
Revance Therapeutics has a market cap or net worth of $554.52 million as of October 23, 2024. Its market cap has decreased by -37.95% in one year.
Market Cap
554.52M
Enterprise Value
813.91M
1-Year Change
-37.95%
Ranking
Category
Stock Price
$5.29
Market Cap Chart
Since February 6, 2014, Revance Therapeutics's market cap has increased from $453.20M to $554.52M, an increase of 22.36%. That is a compound annual growth rate of 1.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2024 | 554.50M | -28.16% |
| Dec 29, 2023 | 771.90M | -49.18% |
| Dec 30, 2022 | 1.52B | 29.62% |
| Dec 31, 2021 | 1.17B | -37.87% |
| Dec 31, 2020 | 1.89B | 157.62% |
| Dec 31, 2019 | 732.10M | -1.68% |
| Dec 31, 2018 | 744.60M | -32.67% |
| Dec 29, 2017 | 1.11B | 87.35% |
| Dec 30, 2016 | 590.30M | -38.42% |
| Dec 31, 2015 | 958.60M | 138.58% |
| Dec 31, 2014 | 401.80M | -11.34% |
| Feb 6, 2014 | 453.20M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyePoint Pharmaceuticals | 575.32M |
| Savara | 569.52M |
| Prime Medicine | 567.79M |
| Aura Biosciences | 565.01M |
| Q32 Bio | 563.19M |
| Third Harmonic Bio | 550.30M |
| Surmodics | 546.14M |
| SI-BONE | 541.19M |